KTRA — Kintara Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $13.94m
- $17.84m
Annual cashflow statement for Kintara Therapeutics, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.05 | -9.13 | -38.3 | -22.7 | -14.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.57 | 0.702 | 22.1 | 2.26 | 4.92 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.13 | 0.487 | -2.65 | -0.055 | -2.19 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -6.33 | -7.93 | -18.9 | -20.4 | -11.9 |
| Capital Expenditures | 0 | — | -0.008 | 0 | -0.232 |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | — | — | 0.972 | 0 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | — | 0.964 | 0 | -0.232 |
| Financing Cash Flow Items | — | -0.025 | -0.03 | 0 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.07 | 6.6 | 26 | 21.6 | 1.85 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.25 | -1.33 | 8.14 | 1.24 | -10.2 |